The Research

/ 📊 Combination Therapy - Anti-Discharge + Decongestant

📊 Combination Therapy - Anti-Discharge + Decongestant

Clinical evidence for triple-combination therapy addressing multiple allergic rhinitis symptoms through synergistic mechanisms.

Articles

Combination Therapy - Anti-Discharge + Decongestant

Ipratropium-Xylometazoline for a Runny Nose: What the Research Says

Ronald Eccles, Anette Pedersen, Dan Regberg

American Journal of Rhinology & Allergy • 2007

This randomized, double-blind, placebo-controlled study assessed the safety and effectiveness of a nasal spray combining ipratropium bromide (an anticholinergic agent) and xylometazoline (a decongestant) in treating rhinorrhea and nasal congestion associated with the common cold. Over a 7-day treatment period, patients scored symptoms and tracked tissue use, with five different treatment arms studied.